ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Vistagen Therapeutics Inc

Vistagen Therapeutics Inc (VTGN)

2,655
-0,105
(-3,80%)
Geschlossen 11 März 9:00PM
2,67
0,015
(0,56%)
Nach Börsenschluss: 12:59AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
2,655
Gebot
2,60
Fragen
2,75
Volumen
110.587
2,62 Tagesbereich 2,83
2,22 52-Wochen-Bereich 5,74
Marktkapitalisierung
Handelsende
2,76
Handelsbeginn
2,71
Letzte Trade
36
@
2.6367
Letzter Handelszeitpunkt
Finanzvolumen
US$ 297.966
VWAP
2,6944
Durchschnittliches Volumen (3 Mio.)
257.819
Ausgegebene Aktien
28.862.085
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,62
Gewinn pro Aktie (EPS)
-1,02
Erlöse
1,06M
Nettogewinn
-29,36M

Über Vistagen Therapeutics Inc

Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five ... Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five clinical-stage investigational agents belonging to a new class of drugs known as pherines. Its portfolio includes PH94B, a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia. PH10, an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Carson City, Nevada, USA
Gegründet
-
Vistagen Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VTGN. The last closing price for Vistagen Therapeutics was US$2,76. Over the last year, Vistagen Therapeutics shares have traded in a share price range of US$ 2,22 to US$ 5,74.

Vistagen Therapeutics currently has 28.862.085 shares in issue. The market capitalisation of Vistagen Therapeutics is US$79,66 million. Vistagen Therapeutics has a price to earnings ratio (PE ratio) of -2.62.

VTGN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.025-0.9328358208962.682.82992.351617292.65868729CS
4-0.175-6.183745583042.833.12.351737892.76060531CS
120.24510.16597510372.413.3952.222578192.78540505CS
26-0.6693-20.13356195293.32433.3952.222259032.84267192CS
52-1.535-36.63484486874.195.742.221893663.43907219CS
156-34.845-92.9237.553.71.6229625866.88683924CS
260-10.845-80.333333333313.5106.51.62249811721.55704538CS

VTGN - Frequently Asked Questions (FAQ)

What is the current Vistagen Therapeutics share price?
The current share price of Vistagen Therapeutics is US$ 2,655
How many Vistagen Therapeutics shares are in issue?
Vistagen Therapeutics has 28.862.085 shares in issue
What is the market cap of Vistagen Therapeutics?
The market capitalisation of Vistagen Therapeutics is USD 79,66M
What is the 1 year trading range for Vistagen Therapeutics share price?
Vistagen Therapeutics has traded in the range of US$ 2,22 to US$ 5,74 during the past year
What is the PE ratio of Vistagen Therapeutics?
The price to earnings ratio of Vistagen Therapeutics is -2,62
What is the cash to sales ratio of Vistagen Therapeutics?
The cash to sales ratio of Vistagen Therapeutics is 72,36
What is the reporting currency for Vistagen Therapeutics?
Vistagen Therapeutics reports financial results in USD
What is the latest annual turnover for Vistagen Therapeutics?
The latest annual turnover of Vistagen Therapeutics is USD 1,06M
What is the latest annual profit for Vistagen Therapeutics?
The latest annual profit of Vistagen Therapeutics is USD -29,36M
What is the registered address of Vistagen Therapeutics?
The registered address for Vistagen Therapeutics is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701
What is the Vistagen Therapeutics website address?
The website address for Vistagen Therapeutics is www.vistagen.com
Which industry sector does Vistagen Therapeutics operate in?
Vistagen Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CAPSCapstone Holding Corp
US$ 3,11
(1.144,00%)
74,5k
HMRHeidmar Maritime Holdings Corporation
US$ 2,5599
(69,53%)
37,58M
RDFNRedfin Corporation
US$ 9,76
(67,70%)
92,54M
CKPTCheckpoint Therapeutics Inc
US$ 3,9895
(61,52%)
60,92M
STSSSharps Technology Inc
US$ 0,4399
(48,26%)
591,61M
APEDSTKd 100 percent MSTR and 100 percent COIN ETF
US$ 11,591
(-35,98%)
2,58k
SXTCChina SXT Pharmaceuticals Inc
US$ 2,78
(-35,54%)
162,75k
PCLAPicoCELA Inc
US$ 0,8499
(-35,12%)
866,6k
CONLGraniteShares ETF Trust GraniteShares
US$ 15,685
(-34,86%)
8,63M
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 19,22
(-32,95%)
24,05M
STSSSharps Technology Inc
US$ 0,4399
(48,26%)
591,61M
NVDANVIDIA Corporation
US$ 106,98
(-5,07%)
364,12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,3701
(-30,86%)
258,67M
TSLATesla Inc
US$ 222,15
(-15,43%)
188,57M
TQQQProShares UltraPro QQQ
US$ 59,81
(-11,27%)
155,18M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen